Average Co-Inventor Count = 4.86
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Targegen, Inc. (8 from 13 patents)
2. Phenex Pharmaceuticals Ag (2 from 11 patents)
3. Phenix Pharmaceuticals Ag (1 from 1 patent)
11 patents:
1. 8481536 - Benzotriazine inhibitors of kinases
2. 8372971 - Heterocyclic compounds and methods of use
3. 8084618 - Heterocyclic compounds and methods of use
4. 8030487 - 2-amino—5-substituted pyrimidine inhibitors
5. 7691858 - Kinase inhibitors and methods of use thereof
6. 7652051 - Heterocyclic compounds and methods of use
7. 7456176 - Benzotriazine inhibitors of kinases
8. 7208493 - Vasculostatic agents and methods of use thereof
9. 7098336 - FXR NR1H4 nuclear receptor binding compounds
10. 7034046 - NR1H4 nuclear receptor binding compounds
11. 6974830 - NR1H4 nuclear receptor binding compounds